ondansetron has been researched along with Cholestasis, Intrahepatic in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Cholestasis, Intrahepatic: Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schumann, R | 1 |
| Hudcova, J | 1 |
| Schwörer, H | 1 |
| Ramadori, G | 1 |
1 review available for ondansetron and Cholestasis, Intrahepatic
| Article | Year |
|---|---|
[Cholestatic pruritus--pathophysiology and therapy with special reference to treatment with 5-hydroxytryptamine subtype 3 receptor antagonists].
Topics: Adult; Child; Cholestasis, Intrahepatic; Female; Humans; Indoles; Male; Nociceptors; Ondansetron; Pr | 1995 |
1 other study available for ondansetron and Cholestasis, Intrahepatic
| Article | Year |
|---|---|
Cholestasis of pregnancy, pruritus and 5-hydroxytryptamine 3 receptor antagonists.
Topics: Cesarean Section; Cholestasis, Intrahepatic; Dose-Response Relationship, Drug; Female; Follow-Up Stu | 2004 |